TomoTherapy Cancer Treatment Technology Debuts in Switzerland

MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TTPY) announced today that the University Hospital of Lausanne (CHUV) has begun treating patients with the TomoTherapy® Hi-Art® treatment system, the first to be installed in Switzerland.

MORE ON THIS TOPIC